The FACS analysis of immune cell profiles showed that the expression of USP12 was negatively correlated with tumor-associated macrophages (TAMs) and PD-L1 (CD274), which were significant for tumor immune therapies [82, 83]. This evidence concerns the gene USP12 and neoplasm.